Silvant Capital Management LLC Exact Sciences Corp Transaction History

Silvant Capital Management LLC

$2.23 Billion
Q3 2024

A detailed history of Silvant Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Silvant Capital Management LLC holds 14,438 shares of EXAS stock, worth $838,992. This represents 0.04% of its overall portfolio holdings.

Number of Shares

14,438

Previous 14,846 2.75%

Holding current value

$838,992

Previous $627,000 56.78%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$42.43 - $70.83 $17,311 - $28,898	-408 Reduced 2.75%	14,438 $983,000
Q2 2024 Jul 25, 2024	SELL	$41.33 - $74.26 $8,927 - $16,040	-216 Reduced 1.43%	14,846 $627,000
Q1 2024 Apr 30, 2024	BUY	$56.27 - $73.77 $53,062 - $69,565	943 Added 6.68%	15,062 $1.04 Million
Q4 2023 Jan 25, 2024	SELL	$59.06 - $75.72 $128,809 - $165,145	-2,181 Reduced 13.38%	14,119 $1.04 Million
Q3 2023 Oct 24, 2023	SELL	$65.94 - $99.04 $51,631 - $77,548	-783 Reduced 4.58%	16,300 $1.11 Million
Q2 2023 Jul 25, 2023	BUY	$62.68 - $95.05 $70,389 - $106,741	1,123 Added 7.04%	17,083 $1.6 Million
Q1 2023 Apr 26, 2023	SELL	$47.19 - $70.77 $15,006 - $22,504	-318 Reduced 1.95%	15,960 $1.08 Million
Q4 2022 Jan 23, 2023	BUY	$30.35 - $53.15 $8,194 - $14,350	270 Added 1.69%	16,278 $0
Q3 2022 Nov 09, 2022	SELL	$31.97 - $49.37 $3,069 - $4,739	-96 Reduced 0.6%	16,008 $520,000
Q2 2022 Aug 03, 2022	BUY	$35.61 - $76.23 $925 - $1,981	26 Added 0.16%	16,104 $635,000
Q1 2022 May 05, 2022	SELL	$57.56 - $82.54 $12,030 - $17,250	-209 Reduced 1.28%	16,078 $1.12 Million
Q4 2021 Feb 07, 2022	SELL	$72.5 - $100.68 $55,462 - $77,020	-765 Reduced 4.49%	16,287 $1.27 Million
Q3 2021 Nov 08, 2021	SELL	$90.24 - $124.05 $307,628 - $422,886	-3,409 Reduced 16.66%	17,052 $1.63 Million
Q2 2021 Aug 03, 2021	SELL	$93.66 - $139.27 $34,654 - $51,529	-370 Reduced 1.78%	20,461 $2.54 Million
Q1 2021 May 11, 2021	SELL	$116.57 - $155.01 $74,604 - $99,206	-640 Reduced 2.98%	20,831 $2.75 Million
Q4 2020 Feb 05, 2021	SELL	$99.61 - $142.12 $42,732 - $60,969	-429 Reduced 1.96%	21,471 $2.85 Million
Q3 2020 Nov 09, 2020	SELL	$72.92 - $102.01 $422,644 - $591,249	-5,796 Reduced 20.93%	21,900 $2.23 Million
Q2 2020 Aug 11, 2020	SELL	$55.75 - $92.75 $103,193 - $171,680	-1,851 Reduced 6.26%	27,696 $2.41 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $22,398 - $61,724	-591 Reduced 1.96%	29,547 $1.71 Million
Q4 2019 Feb 10, 2020	SELL	$77.66 - $99.74 $28,345 - $36,405	-365 Reduced 1.2%	30,138 $2.79 Million
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $372,414 - $504,781	-4,121 Reduced 11.9%	30,503 $2.76 Million
Q2 2019 Aug 09, 2019	BUY	$89.51 - $118.04 $1.01 Million - $1.33 Million	11,241 Added 48.07%	34,624 $4.09 Million
Q1 2019 May 10, 2019	BUY	$61.98 - $96.5 $1.45 Million - $2.26 Million	23,383 New	23,383 $2.03 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Account

Silvant Capital Management LLC Exact Sciences Corp Transaction History